AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CLOMIFENE CITRATE
8 registrations across 3 African markets— 8 active
Markets with CLOMIFENE CITRATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Clomibex Tablet_ Tablet | 🇳🇬Nigeria | Standard Generics Limited | active | Nov 2030 |
| Clomifene Tablets Tablet | 🇳🇬Nigeria | Anyi-Tex Pharmaceuticals Limited | active | Nov 2028 |
| Clomid Tablet Tablet | 🇳🇬Nigeria | Euromed Limited | active | Aug 2028 |
| Clomitab 50 Tablet Tablet | 🇳🇬Nigeria | Onifam Laboratories Limited | active | Sept 2026 |
| OVATRATE 50MG Tablets | 🇹🇿Tanzania | Bharat Serums and Vaccines Limited | active | — |
| Ova-Mit Tablets | 🇹🇿Tanzania | Remedica LTD | active | — |
| Fertab - 50 Tablets | 🇹🇿Tanzania | Oman Pharmaceutical Products Co., LLC | active | — |
| CLOMILEN comprimé / 50 mg | 🇸🇳Senegal | EXPHAR S.A | active | — |
CLOMIFENE CITRATE in Africa — Regulatory Overview
CLOMIFENE CITRATE is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Tanzania, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 8 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.